For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Bio-Techne Corp (NASDAQ: TECH) closed the day trading at $49.26 down -8.90% from the previous closing price of $54.07. In other words, the price has decreased by -$8.90 from its previous closing price. On the day, 2.7 million shares were traded. TECH stock price reached its highest trading level at $52.65 during the session, while it also had its lowest trading level at $48.4.
Ratios:
For a better understanding of TECH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 43.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 30.62. For the most recent quarter (mrq), Quick Ratio is recorded 2.77 and its Current Ratio is at 3.94. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.
On March 18, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $75.
Robert W. Baird Downgraded its Outperform to Neutral on February 19, 2025, whereas the target price for the stock was revised from $88 to $68.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 14 ’25 when Herr Amy E. sold 1,860 shares for $65.96 per share. The transaction valued at 122,691 led to the insider holds 1,976 shares of the business.
JOSHUA MOLHO bought 1,860 shares of TECH for $122,691 on Feb 14 ’25. On Jan 27 ’25, another insider, Kelderman Kim, who serves as the Chief Executive Officer of the company, sold 13,392 shares for $77.29 each. As a result, the insider received 1,035,013 and left with 39,004 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TECH now has a Market Capitalization of 7787414528 and an Enterprise Value of 8393872896. As of this moment, Bio-Techne’s Price-to-Earnings (P/E) ratio for their current fiscal year is 50.07, and their Forward P/E ratio for the next fiscal year is 22.58. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.51 while its Price-to-Book (P/B) ratio in mrq is 3.74. Its current Enterprise Value per Revenue stands at 7.018 whereas that against EBITDA is 27.118.
Stock Price History:
The Beta on a monthly basis for TECH is 1.45, which has changed by -0.2618013 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, TECH has reached a high of $85.57, while it has fallen to a 52-week low of $46.44. The 50-Day Moving Average of the stock is -21.50%, while the 200-Day Moving Average is calculated to be -31.06%.
Shares Statistics:
Over the past 3-months, TECH traded about 1.80M shares per day on average, while over the past 10 days, TECH traded about 2525300 shares per day. A total of 157.92M shares are outstanding, with a floating share count of 156.31M. Insiders hold about 1.12% of the company’s shares, while institutions hold 100.09% stake in the company. Shares short for TECH as of 1741910400 were 6265697 with a Short Ratio of 3.36, compared to 1739491200 on 5076499. Therefore, it implies a Short% of Shares Outstanding of 6265697 and a Short% of Float of 4.5500003.
Dividends & Splits
TECH’s forward annual dividend rate is 0.32, up from 0.32 a year ago. Against a Trailing Annual Dividend Yield of 0.005918254The stock’s 5-year Average Dividend Yield is 0.4. The current Payout Ratio is 30.61% for TECH, which recently paid a dividend on 2025-02-14 with an ex-dividend date of 1739491200. Stock splits for the company last occurred on 2022-11-30 when the company split stock in a 4:1 ratio.
